Literature DB >> 18503063

Dosimetric audits of photon beams in radiation therapy centres in Rio de Janeiro, Brazil.

L A R da Rosa1, R R A Brito, M Gonçalves, E de Paiva, A C M Dovales, B L V Freire, R A Giannoni, R Di Prinzio, A F Velasco, L H R Castelo, R V Oliveira.   

Abstract

Data related to 11 y of high-energy photon radiotherapy beam dosimetry are presented and analysed. Dosimetric evaluations were carried out using water phantoms and thimble ionisation chambers and are part of the radiation protection regulatory licensing process for medicine facilities of Brazilian government. Measurements were done at reference conditions for a standard absorbed dose of 100 cGy [cGy (=1 rad)]. The absolute per cent deviation between the measured and presumed delivered doses should not exceed the tolerance level of +/-3%. The first dosimetry survey from 1996 to 1998 showed a situation that was an object of concern. Deviations of 22 and 18.7% could be measured, although small deviations were also obtained. After 1998, the improvement in dosimetry quality control by the radiotherapy centres became clear, with most of the deviations situated within the +/-3% range. The decrease in the measured deviations presents the effective success of the Institute of Radiation Protection and Dosimetry audit programme for the improvement in the control of radiotherapy photon beams in Rio de Janeiro. Also, it is possible to recommend to Brazilian regulatory organisation a decrease in the tolerance level for dosimetric deviations in order to achieve a more precise dose delivered to patients in radiotherapy centres.

Entities:  

Mesh:

Year:  2008        PMID: 18503063     DOI: 10.1093/rpd/ncn169

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  1 in total

1.  An analysis of the regulatory program of quality audits in radiotherapy in Brazil from 1995 to 2007.

Authors:  Eduardo de Paiva; Luiz A R da Rosa; Ricardo R A Brito; Lidia V de Sá; Ana C M Dovales; Delano V S Batista; Ricardo A Giannoni; Alexandre F Velasco
Journal:  J Appl Clin Med Phys       Date:  2011-01-30       Impact factor: 2.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.